Search results for "opioid"

showing 10 items of 320 documents

Neuroimmune and Mu-Opioid Receptor Alterations in the Mesocorticolimbic System in a Sex-Dependent Inflammatory Pain-Induced Alcohol Relapse-Like Rat …

2021

Evidence concerning the role of alcohol-induced neuroinflammation in alcohol intake and relapse has increased in the last few years. It is also proven that mu-opioid receptors (MORs) mediate the reinforcing properties of alcohol and, interestingly, previous research suggests that neuroinflammation and MORs could be related. Our objective is to study neuroinflammatory states and microglial activation, together with adaptations on MOR expression in the mesocorticolimbic system (MCLS) during the abstinence and relapse phases. To do so, we have used a sex-dependent rat model of complete Freund’s adjuvant (CFA)-induced alcohol deprivation effect (ADE). Firstly, our results confirm that only CFA-…

Malemedicine.medical_treatmentFreund's AdjuvantReceptors Opioid mualcohol deprivation effectNitric Oxide Synthase Type IImicroglianeuroinflammationRats Sprague-DawleyRecurrenceLimbic SystemImmunology and AllergypainPhosphorylationReceptormedia_commonMicrogliaAlcohol AbstinencealcoholMicrofilament ProteinsNF-kappa BBrief Research ReportInterleukin 10AlcoholismCytokinemedicine.anatomical_structureCytokinesFemaleμ-opioid receptorInflammation Mediatorsmedicine.medical_specialtyNeuroimmunomodulationmedia_common.quotation_subjectImmunologyPrefrontal CortexSex FactorsDownregulation and upregulationInternal medicinemedicineAnimalsNeuroinflammationbusiness.industryCalcium-Binding ProteinsAbstinenceRC581-607EndocrinologyCyclooxygenase 2mu-opioid receptorImmunologic diseases. AllergybusinessFrontiers in Immunology
researchProduct

Controlled sedation for refractory symptoms in dying patients.

2008

Terminally ill cancer patients near the end of life may experience intolerable suffering refractory to palliative treatment. Although sedation is considered to be an effective treatment when aggressive efforts fail to provide relief in terminally ill patients, it remains controversial. The aim of this study was to assess the need and effectiveness of sedation in dying patients with intractable symptoms, and the thoughts of relatives regarding sedation. A prospective cohort study was performed on a consecutive sample of dying patients admitted to an acute pain relief and palliative care unit within a cancer center. Indications for sedation, opioid and midazolam doses, level of delirium and s…

Malerefractory symptomPalliative carePalliative treatmentSedationPainRefractoryNeoplasmscontrolled sedationmedicineHumansProspective cohort studyGeneral NursingPain MeasurementTerminal Caredying patientsbusiness.industryPalliative CareMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicineTreatment OutcomeOpioidAnesthesiaMidazolamDeliriumFemaleNeurology (clinical)medicine.symptombusinessmedicine.drug
researchProduct

Opioid switching in patients with advanced cancer followed at home. A retrospective analysis.

2013

Abstract CONTEXT: Opioid switching has been found to improve opioid responsiveness in different conditions. However, data on opioid switching performed at home are almost nonexistent, despite the fact that most patients are followed at home. OBJECTIVES: The aim of this retrospective survey was to determine frequency, indications, usefulness, and safety of opioid switching when treating advanced cancer-related pain in patients followed at home. METHODS: A retrospective review of data from patients with advanced cancer followed at home by three home care teams for a period of two years was performed. Patients who had their opioids switched were selected. Reasons for switching opioid doses and…

Maleretrospective studyComorbiditySettore MED/42 - Igiene Generale E Applicataadvanced cancer patientNeoplasmsRetrospective analysisPrevalenceOpioid switching; advanced cancer patients; retrospective studyCancer painProspective cohort studyNursing (all)2901 Nursing (miscellaneous)General NursingAnalgesicsDrug SubstitutionHome Care ServicesAnalgesics OpioidCausalitySurvival RateTreatment OutcomeItalyFemaleDrugmedicine.drugmedicine.medical_specialtyAnalgesicPainContext (language use)OpioidDose-Response RelationshipmedicineHumansIn patientIntensive care medicineAgedRetrospective StudiesDose-Response Relationship Drugbusiness.industryAdvanced cancerSurvival AnalysisCancer pain; home care; opioid switching; Aged; Analgesics Opioid; Causality; Comorbidity; Dose-Response Relationship Drug; Drug Substitution; Female; Home Care Services; Humans; Italy; Male; Neoplasms; Pain; Prevalence; Quality of Life; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)Anesthesiology and Pain MedicineOpioidEmergency medicineMorphineOpioid switchingQuality of LifeNeurology (clinical)home carebusinessJournal of pain and symptom management
researchProduct

Equipotent doses to switch from high doses of opioids to transdermal buprenorphine.

2008

INTRODUCTION: The aim of this study was to evaluate the equianalgesic ratio of transdermal buprenorphine (TD BUP) with oral morphine and TD fentanyl in a sample of consecutive cancer patients receiving stable doses of 120-240 mg of oral morphine or 50-100 microg of TD fentanyl, reporting adequate pain and symptom control. MATERIALS, METHODS, AND RESULTS: Patients receiving daily stable doses of opioids for more than 6 days, with no more than two doses of oral morphine (20 and 40 mg, respectively) as needed, were switched to TD BUP using a fentanyl-BUP ratio of 0.6:0.8 and an oral morphine-BUP ratio of 70:1. Opioid doses, pain and symptom intensity, global satisfaction, and number of breakth…

Maletransdermal buprenorphinePainAdministration CutaneousFentanylNeoplasmsHigh dosesMedicineHumansSymptom controlProspective StudiesOral morphineAgedDose-Response Relationship Drugbusiness.industryMiddle AgedEquianalgesicBuprenorphineAnalgesics OpioidFentanylOncologyPatient SatisfactionAnesthesiaFemaleTransdermal Buprenorphinehigh doses of opioidsbusinessCancer painmedicine.drugSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

Intraoperative clonidine modulates sympathetic tone in the early postoperative period after remifentanil. A double blind, placebo-controlled study

1999

Abstract Aim of the study : Severe pain following major surgery can impair the control of the cardiovascular system (CVS) by causing sympathetic stimulation, possibly leading to myocardial ischaemia. In this study we examine the influence of intraoperative intravenous (i.v.) clonidine infusion on postoperative analgesia and blood concentrations of noradrenaline and adrenaline after major gynaecological surgery. Methods : All patients underwent an abdominal hysterectomy under balanced general anaesthesia using the new opioid remifentanil. The patients were randomised to receive either 5 μg kg −1 of i.v. clonidine intraoperatively ( n =20), or placebo ( n =20). Over a period of 240 minutes po…

Mean arterial pressurebusiness.industryPatient-controlled analgesiamedicine.medical_treatmentRemifentanilHemodynamicsPiritramideClonidineAnesthesiology and Pain MedicineOpioidAnesthesiaEmergency MedicinemedicineGeneral anaesthesiabusinessmedicine.drugAcute Pain
researchProduct

Symptom burden in mesothelioma patients admitted to home palliative care

2016

Context: Mesothelioma is a very aggressive cancer that is brought on by asbestos exposure. Because there is a long latency period between exposure to asbestos and symptoms of disease, most patients with mesothelioma present with advanced disease and survive an average of 8–12 months. Thus, best supportive care should be considered critical to optimally manage these patients. Aim: The aim of this study was to examine the epidemiological characteristics and symptom burden of mesothelioma patients when admitted to home palliative care. Methods: The charts of a consecutive sample of patients admitted to the home palliative care program with a diagnosis of mesothelioma in an endemic industrial…

MesotheliomaHome Care ServiceMalemedicine.medical_specialtyPalliative careDiseasemedicine.disease_causeAsbestos03 medical and health sciences0302 clinical medicineRetrospective StudieEpidemiologymedicineHumans030212 general & internal medicineMesotheliomaIntensive care medicineRetrospective StudiesAgedAged 80 and overbusiness.industryMedicine (all)Palliative CareSymptom burdenRetrospective cohort studyGeneral MedicineCancer PainMiddle Agedmedicine.diseaseHome Care ServicesAnalgesics OpioidDyspnea030220 oncology & carcinogenesisEmergency medicineFemalebusinessCancer painHuman
researchProduct

Effect Of Inflammatory Pain On Alcohol-Induced Dopamine Release In The Nucleus Accumbens: Behavioural Implications In Rat Models

2019

AbstractRecent studies have drawn the attention to the link between Alcohol Use Disorder (AUD) and the presence of pain. Indeed, the correct management of pain in patients with a previous history of AUD has been reported to decrease the risk of relapse in alcohol drinking, suggesting that in this prone population, pain may increase the vulnerability to relapse. Previous data in male rats revealed that inflammatory pain desensitizes mu opioid receptors (MORs) in the ventral tegmental area (VTA) and increases intake of high doses of heroine. Due to the relevant role of MORs in alcohol effects, we hypothesize that pain may also alter alcohol reinforcing properties and therefore affect alcohol …

Microdialysiseducation.field_of_studymedicine.medical_specialtybusiness.industryPopulationAlcohol use disorderNucleus accumbensmedicine.diseaseVentral tegmental areamedicine.anatomical_structureEndocrinologyNeurochemicalDopamineInternal medicineMedicineμ-opioid receptorbusinesseducationmedicine.drug
researchProduct

Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits.

2006

The role of μ3 opioid receptors in morphine-induced intraocular pressure (IOP) lowering effect and miosis was evaluated in conscious, dark-adapted New Zealand white (NZW) rabbits using a masked-design study. IOP and pupil diameter (PD) measurements were taken at just before and 0.5, 1, 2, 4, 6 h after monolateral instillation of morphine (10, 50 and 100 μg/30 μl) as compared to vehicle administered in the contralateral eye. Morphine-induced ocular effects were challenged by a pre-treatment with the non-selective opioid receptor antagonist, naloxone (100 μg/30 μl), the nitric oxide synthase inhibitor, Nω-nitro-l-arginine methyl ester (l-NAME, 1%, 30 μl), or the non-selective μ3 opioid recept…

MiosisIntraocular pressureTime FactorsPupil diametergenetic structuresmedicine.drug_classNarcotic AntagonistsReceptors Opioid muRabbit(+)-NaloxonePharmacologyEyeNitric OxideNitric oxidechemistry.chemical_compoundOpioid receptormedicineEnzyme InhibitorAnimalsEnzyme InhibitorsIntraocular PressurePharmacologybiologyDose-Response Relationship DrugMorphineAnimalNaloxoneMiosisGlutathioneeye diseasesNitric oxide synthaseAnalgesics OpioidNG-Nitroarginine Methyl EsterchemistryOpioidAnesthesiaMorphinebiology.proteinsense organsRabbitsmedicine.symptomNitric Oxide SynthaseOpioid receptorMiosiNarcotic Antagonistmedicine.drugEuropean journal of pharmacology
researchProduct

Efficacy of fentanyl transdermal patch in pain control after lower third molar surgery: A preliminary study

2015

Background Surgical removal of impacted lower third molars is a common oral surgical procedure, generally followed by moderate to severe postoperative pain. Transdermal drug delivery as a concept offers interesting possibilities for postoperative pain control. The aim of this study was to evaluate the efficacy of transdermal system with fentanyl in relieving pain following impacted lower third molar surgery. Material and Methods Seventeen patients with bilateral impacted lower third molars were included in this preliminary study. For postoperative pain control, patients randomly received a fentanyl patch plus placebo tablet after the first operation and regular (placebo) patch and an analge…

Molarmedicine.medical_specialtyTransdermal patchVisual analogue scaleAnalgesicTransdermal PatchPlaceboFentanyllaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawmedicineHumansPain ManagementGeneral Dentistrythird molar surgeryTransdermalPain Postoperativetransdermal administrationbusiness.industryResearchTooth Impactedacute pain030206 dentistry:CIENCIAS MÉDICAS [UNESCO]postoperative care3. Good healthSurgeryAnalgesics OpioidFentanylOtorhinolaryngologyAnesthesiaTooth ExtractionUNESCO::CIENCIAS MÉDICASMolar ThirdSurgeryAnalgesiaOral Surgerybusiness030217 neurology & neurosurgerymedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Comparison of the analgesic efficacy of oral ketorolac versus intramuscular tramadol after third molar surgery: A parallel, double-blind, randomized,…

2015

Background Preemptive analgesia is considered an alternative for treating the postsurgical pain of third molar removal. The aim of this study was to evaluate the preemptive analgesic efficacy of oral ketorolac versus intramuscular tramadol after a mandibular third molar surgery. Material and Methods A parallel, double-blind, randomized, placebo-controlled clinical trial was carried out. Thirty patients were randomized into two treatment groups using a series of random numbers: Group A, oral ketorolac 10 mg plus intramuscular placebo (1 mL saline solution); or Group B, oral placebo (similar tablet to oral ketorolac) plus intramuscular tramadol 50 mg diluted in 1 mL saline solution. These tre…

Molarmedicine.medical_specialtymedicine.medical_treatmentAnalgesicPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawmedicineHumansAdverse effectGeneral DentistrySalineTramadolPain MeasurementAnalgesicsPain Postoperativebusiness.industryResearchAnti-Inflammatory Agents Non-SteroidalTooth Impacted030206 dentistry:CIENCIAS MÉDICAS [UNESCO]SurgeryKetorolacbody regionsAnalgesics OpioidOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryMolar ThirdTramadolOral SurgerybusinessKetorolac030217 neurology & neurosurgerymedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct